These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 2410766)

  • 21. [Long-term survival in terms of DNA-RNA contents in breast cancer].
    Hara S; Kondo M; Tagawa Y; Itoyanagi N; Kishimoto K; Matuo S; Akamine S; Takahashi T; Oka T; Ayabe H
    Gan To Kagaku Ryoho; 1998 Apr; 25 Suppl 3():422-5. PubMed ID: 9589046
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nuclear DNA content in different histologic types of breast carcinoma.
    Olinici CD; Căluşer I
    Morphol Embryol (Bucur); 1988; 34(4):243-7. PubMed ID: 2976886
    [No Abstract]   [Full Text] [Related]  

  • 23. [Malignancy grading in breast cancer as assessed by nuclear DNA content].
    Nishi T; Okajima K; Taguchi T; Mizutani H; Sogabe T; Uragami I; Sekimoto T
    Nihon Geka Gakkai Zasshi; 1988 Apr; 89(4):576-81. PubMed ID: 3405196
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Classifying breast carcinomas with DNA measurements and morphometry.
    Boon ME; Auer GU; van Kaam H; Schwinghammer H
    Cytometry; 1984 Sep; 5(5):469-72. PubMed ID: 6489060
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [DNA content/of breast cancer before and after large-fractionated irradiation].
    Shiukashvili NN
    Med Radiol (Mosk); 1976 Jul; 21(7):25-9. PubMed ID: 979537
    [No Abstract]   [Full Text] [Related]  

  • 26. [Clinical morphology of early breast cancer].
    Serov VV; Zolotarevskiĭ VB
    Arkh Patol; 1979; 41(1):3-11. PubMed ID: 426637
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic significance of nuclear DNA content in mammary adenocarcinomas in humans.
    Auer G; Eriksson E; Azavedo E; Caspersson T; Wallgren A
    Cancer Res; 1984 Jan; 44(1):394-6. PubMed ID: 6690053
    [TBL] [Abstract][Full Text] [Related]  

  • 28. DAPI fluorescence in nuclei isolated from tumors.
    Krishan A; Dandekar PD
    J Histochem Cytochem; 2005 Aug; 53(8):1033-6. PubMed ID: 16055751
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Progression of mammary adenocarcinomas as reflected by nuclear DNA content.
    Auer GU; Fallenius AG; Erhardt KY; Sundelin BS
    Cytometry; 1984 Jul; 5(4):420-5. PubMed ID: 6468180
    [TBL] [Abstract][Full Text] [Related]  

  • 30. DNA-ploidy studies on cytological preparations from breast cancers by image analysis: comparison with Feulgen staining performed in destained Papanicolaou slides.
    Sidoni A; Cavaliere A; Alunno P; Bucciarelli E
    Cytometry; 1996 Dec; 26(4):293-7. PubMed ID: 8979029
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Comparative study of nuclear DNA content between fine needle aspirates and paraffin-embedded tissue samples of breast cancer: preliminary report].
    Kurihara T; Yokoe T; Ishida T; Izuo M
    Nihon Geka Gakkai Zasshi; 1990 Mar; 91(3):438. PubMed ID: 2359401
    [No Abstract]   [Full Text] [Related]  

  • 32. Introduction of the cytological grading, the nuclear area, the DNA index and the DNA histogram type in the setting up of a score for ductal breast carcinoma.
    Budel V; Merle S; Gasperin P; Collet JF; De Maublanc MA; Kiss R
    Anticancer Res; 1994; 14(6B):2845-51. PubMed ID: 7532932
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mutant p53 expression and DNA analysis in human breast cancer comparison with conventional clinicopathological parameters.
    Rosanelli GP; Steindorfer P; Wirnsberger GH; Klimpfinger M; Ratschek M; Puerstner P; Auner H; Berhold A
    Anticancer Res; 1995; 15(2):581-6. PubMed ID: 7763041
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The objective comparison of nuclear DNA content with nuclear grade in breast cancer].
    Yamamoto N
    Nihon Geka Gakkai Zasshi; 1995 Apr; 96(4):236-44. PubMed ID: 7753019
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relationship between nuclear DNA distribution and estrogen receptors in human mammary carcinomas.
    Auer GU; Caspersson TO; Gustafsson SA; Humla SA; Ljung BM; Nordenskjöld BA; Silfverswärd C; Wallgren AS
    Anal Quant Cytol; 1980 Dec; 2(4):280-4. PubMed ID: 7469203
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Megakaryocyte DNA content in man by microcytofluorometry with DAPI staining after removal of Wright-Giemsa staining].
    Kobayashi Y; Ozawa M; Horiuchi H; Maruo N; Kondo M
    Rinsho Byori; 1988 Sep; 36(9):1065-9. PubMed ID: 2469816
    [No Abstract]   [Full Text] [Related]  

  • 37. [DNA content examination for atypical hyperplasia of adenosis and carcinoma of the breast].
    Jiang J
    Zhonghua Wai Ke Za Zhi; 1992 Nov; 29(12):781-3, 800. PubMed ID: 1618046
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [DNA determinations in breast cancers: cytophotometric proliferation behavior and cyto/histologic malignancy grade].
    Mikuz G
    Verh Dtsch Ges Pathol; 1985; 69():516-9. PubMed ID: 3006392
    [No Abstract]   [Full Text] [Related]  

  • 39. [Clinical significance of measurement of nuclear DNA content in breast cancer].
    Nishi T; Okajima K; Taguchi T; Ryo T; Sekimoto T
    Nihon Geka Gakkai Zasshi; 1989 Sep; 90(9):1559-63. PubMed ID: 2586466
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Contents of nuclear Feulgen-DNA in carcinoma of the breast. Cytophotometric analysis].
    Ricevuti G; Barni S
    Arch Sci Med (Torino); 1983; 140(4):393-400. PubMed ID: 6201153
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.